Provigil (Modafinil) Patent Expiration, LOE Window & CMS Spending

Provigil (Modafinil) by Nuvo (Ireland) Dac: Off-Patent Genericized (AB Competition), 7 AB generics, $33.1M 2024 CMS Part D & Medicaid spend, and 4 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorNuvo (Ireland) Dac
FDA Application & PathwayN020717 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors7
2024 CMS Total Public Spend$33.1M
2024 Medicare Part D Spend$13.2M
2024 Medicaid Spend$19.8M
Reported Wholesale Price Change (CA SB 17)4 WAC filings (max 18.0% 2-yr change)